Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
63,309.40 -577.88 (-0.90%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Phathom Pharmaceuticals, Inc. (PHAT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 537.25M |
| Enterprise value | 294.89M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 690.37 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 432.39 |
| Enterprise value/EBITDA | -1.85 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.63 |
| 52-week change 3 | -17.30% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 17.02 |
| 52-week low 3 | 6.07 |
| 50-day moving average 3 | 9.77 |
| 200-day moving average 3 | 10.14 |
Share statistics
| Avg vol (3-month) 3 | 880.12k |
| Avg vol (10-day) 3 | 506.16k |
| Shares outstanding 5 | 58.52M |
| Implied shares outstanding 6 | 58.52M |
| Float 8 | 43.23M |
| % held by insiders 1 | 8.92% |
| % held by institutions 1 | 88.58% |
| Shares short (15 Apr 2024) 4 | 12.03M |
| Short ratio (15 Apr 2024) 4 | 13.35 |
| Short % of float (15 Apr 2024) 4 | 42.24% |
| Short % of shares outstanding (15 Apr 2024) 4 | 20.56% |
| Shares short (prior month 15 Mar 2024) 4 | 10.44M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -10,245.60% |
Management effectiveness
| Return on assets (ttm) | -36.14% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 682k |
| Revenue per share (ttm) | 0.01 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -166.74M |
| Net income avi to common (ttm) | -201.59M |
| Diluted EPS (ttm) | -3.93 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 381.39M |
| Total cash per share (mrq) | 6.52 |
| Total debt (mrq) | 445.96M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 10.25 |
| Book value per share (mrq) | -1.25 |
Cash flow statement
| Operating cash flow (ttm) | -137.58M |
| Levered free cash flow (ttm) | -90.45M |
© 2024 Yahoo. All rights reserved.